Abstract:Introduction Recombination serves as a common strategy employed by RNA viruses for their genetic evolution. Extensive genomic surveillance during the COVID-19 pandemic has reported SARS-CoV-2 Recombinant strains indicating recombination events during the viral evolution. This study introspects the phenomenon of genome recombination by tracing the footprint of prominent lineages of SARS-CoV-2 at different time points in the context of on-going evolution and emergence of Recombinants. Method Whole genome sequencing was carried out for 2,516 SARS-CoV-2 (discovery cohort) and 1,126 (validation cohort) using nasopharyngeal samples collected between the time period of March 2020 to August 2022, as part of the genomic surveillance program. The sequences were classified according to the different lineages of SARS-CoV-2 prevailing in India at respective time points. Results Mutational diversity and abundance evaluation across the 12 lineages identified 58 Recombinant sequences as harboring the least number of mutations ( n = 111), with 14 low-frequency unique mutations with major chunk of mutations coming from the BA.2. The spontaneously/dynamically increasing and decreasing trends of mutations highlight the loss of mutations in the Recombinants that were associated with the SARS-CoV-2 replication efficiency, infectivity, and disease severity, rendering them functionally with low infectivity and pathogenicity. Linkage disequilibrium (LD) analysis revealed that mutations comprising the LD blocks of BA.1, BA.2, and Recombinants were found as minor alleles or as low-frequency alleles in the LD blocks from the previous SARS-CoV-2 variant samples, especially Pre-VOC. Moreover, a dissipation in the size of LD blocks as well as LD decay along with a high negative regression coefficient (R squared) value was demonstrated in the Omicron and BA.1 and BA.2 lineages, which corroborated with the breakpoint analysis. Conclusion Together, the findings help to understand the evolution and emergence of Recombinants after the Omicron lineages, for sustenance and adaptability, to maintain the epidemic spread of SARS-CoV-2 in the host population already high in immunity levels.

Data-driven recombination detection in viral genomes

Data-driven recombination detection in viral genomes

VirusRecom: an information-theory-based method for recombination detection of viral lineages and its application on SARS-CoV-2

Comprehensive detection and dissection of interlineage recombination events in the SARS-CoV-2 pandemic

Systematic detection of co-infection and intra-host recombination in more than 2 million global SARS-CoV-2 samples

Unraveling the genetic evolution of SARS-CoV-2 Recombinants using mutational dynamics across the different lineages

ViReMa : a virus recombination mapper of next-generation sequencing data characterizes diverse recombinant viral nucleic acids

Parametric inference of recombination in HIV genomes

The nuts and bolts of recombination in the generation of SARS-CoV-2 variants; from XA to XBB

Classification of SARS-CoV-2 sequences as recombinants via a pre-trained CNN and identification of a mathematical signature relative to recombinant feature at Spike, via interpretability

New framework for recombination and adaptive evolution analysis with application to the novel coronavirus SARS-CoV-2

Early detection of emerging viral variants through analysis of community structure of coordinated substitution networks

Analysis of Recombinant Characteristics Based on 949 PRRSV-2 Genomic Sequences Obtained from 1991 to 2021 Shows That Viral Multiplication Ability Contributes to Dominant Recombination

Efficient and accurate detection of viral sequences at single-cell resolution reveals putative novel viruses perturbing host gene expression

Comparative Bioinformatic Analysis Reveals Conserved Regions in SARS-CoV-2 Genome for RAPID Pandemic Response

Concatenation of segmented viral genomes for reassortment analysis

Mining genomic repositories to further our knowledge of the extent of SARS-CoV-2 co-infections

Topological data analysis identifies emerging adaptive mutations in SARS-CoV-2

Real-time identification of epistatic interactions in SARS-CoV-2 from large genome collections

In silico genomic surveillance by CoVerage predicts and characterizes SARS-CoV-2 Variants of Interest

Recombinant SARS-CoV-2 Delta/Omicron BA.5 emerging in an immunocompromised long-term infected COVID-19 patient